Company
United StatesPublic company, NYSE: PFEPfizer, Inc. (NYSE: PFE), Groton, CT – FDA Inspections
Inspection records and compliance data for Pfizer, Inc. in Groton, Connecticut. 26 FDA inspections on record (1 OAI), 6 Form 483s, last inspected October 24, 2025. Publicly traded as NYSE: PFE.
Company Profile
This profile covers Pfizer, Inc. based in Groton, Connecticut, United States.
FDA Inspection History
- FDA inspections
- 26
- OAI
- 1
- VAI
- 9
- NAI
- 13
- Unclassified
- 3
- Form 483s
- 6
- Warning letters
- 0
First inspected June 3, 2009. Last inspected October 24, 2025.
Most cited issue areas
- Ensuring compliance with plan and protocol2 inspections
- General responsibilities of sponsors2 inspections
- Procedures not in writing, fully followed2 inspections
FDA inspections (26)
| Date | Result | FDA center(s) | Insp. # |
|---|---|---|---|
| October 24, 2025 | Not classified | Human Drugs | 1284680 |
| December 13, 2024 | VAI | Human Drugs · Bioresearch Monitoring: Human Drugs | 1256477 |
| August 30, 2024 | Not classified | Human Drugs | 1249289 |
| July 19, 2024 | Not classified | Biologics | 1230476 |
| April 19, 2023 | NAI | Human Drugs · Bioresearch Monitoring | 1204434 |
| October 28, 2022 | NAI | Human Drugs · Bioresearch Monitoring | 1190580 |
| November 19, 2021 | NAI | Human Drugs · Drug Quality Assurance | 1158313 |
| June 4, 2021 | NAI | Human Drugs · Bioresearch Monitoring | 1143781 |
| November 2, 2018 | NAI | Human Drugs · Bioresearch Monitoring | 1075115 |
| October 5, 2018 | NAI | Human Drugs · Bioresearch Monitoring | 1070712 |
| July 18, 2018 | VAI | Human Drugs · New Drug Evaluation | 1059198 |
| June 21, 2018 | VAI | Human Drugs · Bioresearch Monitoring | 1056362 |
| September 22, 2017 | VAI | Human Drugs · Bioresearch Monitoring | 1026537 |
| June 28, 2017 | VAI | Human Drugs · Bioresearch Monitoring | 1018384 |
| June 7, 2017 | VAI | Animal Drugs & Feeds, Human Drugs · Drug Quality Assurance | 1013440 |
| January 12, 2017 | NAI | Human Drugs · Bioresearch Monitoring | 1002433 |
| January 23, 2015 | VAI | Animal Drugs & Feeds, Human Drugs · Drug Quality Assurance | 915225 |
| December 5, 2014 | NAI | Human Drugs · Bioresearch Monitoring | 905800 |
| June 6, 2012 | VAI | Human Drugs · Bioresearch Monitoring | 785216 |
| May 7, 2012 | NAI | Human Drugs · Bioresearch Monitoring | 789037 |
| April 30, 2012 | NAI | Human Drugs · Bioresearch Monitoring | 789034 |
| February 24, 2012 | VAI | Animal Drugs & Feeds, Human Drugs · Drug Quality Assurance | 769343 |
| June 9, 2011 | NAI | Human Drugs · Bioresearch Monitoring | 734309 |
| July 14, 2010 | NAI | Animal Drugs & Feeds, Human Drugs · Drug Quality Assurance | 671915 |
| August 11, 2009 | NAI | Animal Drugs & Feeds · Monitoring of Marketed Animal Drugs, Feed, and Devices | 603585 |
| June 3, 2009 | OAI | Human Drugs · Bioresearch Monitoring | 586238 |
FDA documents
People (5)
Related Companies (10)
Companies with similar regulatory profiles, compliance history, and operations.
Company Information
Name
Pfizer, Inc.
Stock ticker
PFE
Exchange
NYSE
Share price
$28.84
Market cap
$164.4B
Price as of
November 13, 2026
FEI Number
1211022
Address
558 Eastern Point Road, Groton, Connecticut 06340, United States
Country
United States
ID: 4b87fbf2-bec7-4fde-adf0-4207cd7d93ff